Reply to Letter to the Editor “Addressing Gaps in Post-MI Medication Use Study” regarding: “Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia”

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart, Lung and Circulation Pub Date : 2024-12-01 DOI:10.1016/j.hlc.2024.10.007

Adam C. Livori MClinPharm , Zanfina Ademi MPH, PhD , Jenni Ilomäki PhD , Adam J. Nelson MBBS, MPH, MBA, PhD , J. Simon Bell PhD , Jedidiah I. Morton PhD

引用次数: 0

查看原文本刊更多论文

回复致编辑的信 "弥补心肌梗死后用药研究的不足"，内容涉及"心肌梗塞后 12 个月用药模式取决于血管重建策略：对澳大利亚维多利亚州 15,339 例入院患者的分析"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart, Lung and Circulation CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

4.50

自引率

3.80%

发文量

912

审稿时长

11.9 weeks

期刊介绍： Heart, Lung and Circulation publishes articles integrating clinical and research activities in the fields of basic cardiovascular science, clinical cardiology and cardiac surgery, with a focus on emerging issues in cardiovascular disease. The journal promotes multidisciplinary dialogue between cardiologists, cardiothoracic surgeons, cardio-pulmonary physicians and cardiovascular scientists.